http://www.cmemeeting.org/uploads/Sunrise_CG.jpg16th Annual Hypertension Conference:
 Focus on Hypertension, Diabetes and Dyslipidemia


July 27-29, 2012

Hammock Beach Resort
                                        Palm Coast, Florida


OVERVIEWhttp://www.cmemeeting.org/uploads/ASH-JPEG.jpg

In collaboration with the Carolinas, Georgia, Florida Chapter of the American Society of Hypertension, we are pleased to offer the 16th Annual Hypertension Conference: Focus on Hypertension, Diabetes and Dyslipidemia.  This three day intensive conference will be held on July 27-29, 2012 at the Hammock Beach Resort and has been endorsed by the American Society of Hypertension.


The Hammock Beach Resort in Palm Coast, FL, just south of St. Augustine, America's oldest city.  This premier Florida beach destination features luxury villa and condominium accommodations overlooking the Atlantic Ocean, a 91,000 square-foot multi-level water park with lazy river, signature golf courses designed by golf's greatest legends, Jack Nicklaus and Tom Watson, a rejuvenating resort spa with influences from the sea and a host of other recreational amenities that will keep you coming back year after year.  

Physicians attending the conference may chose to lengthen their stay by attending a session of the 3rd Annual Essentials in Primary Care Summer Conference which will take place July 23-27 (Session 1) and July 30-August 3 (Session 2).  Special combination pricing is available as well as one day pricing.


PROGRAM DESCRIPTION  

 

Gaps in the level of Hemoglobin A1C, BP, and LDL-Cholesterol reduction continue to occur in high-risk individuals with Type 2 diabetes, Hypertension, and Dyslipidemia, respectively. Recent results from the ACCORD, VADT, and ADVANCE studies suggest the benefits on reducing macrovascular disease events are unclear and, in fact, caution should be exercised when reducing Hemoglobin A1C in those with long standing Type 2 diabetes to a goal of < 6% when compared to a goal between 7 and 7.9%. In addition, controversy continues from recent guidelines on the level of LDL-cholesterol and BP reduction that can be and should be achieved. This conference will address these and other issues confronting the clinician who treats patients with diabetes, hypertension, and dyslipidemia.  The participant will learn the most current information on these issues and will be able to transport these clinical principles back to their every day practice to improve patient care.

OBJECTIVES
At the completion of this activity, participants should be better prepared to:

• Discuss goals, medications and controversies surrounding management of patients with Diabetes, Hypertension and Dyslipidemia;

• Describe appropriate treatment plans for these individuals; and

• Apply new learning to improve health outcomes involving patients with Diabetes, Hypertension, and Dyslipidemia.


TARGET AUDIENCE
This activity is designed for physicians specializing in Internal Medicine, Family or General Practice, Geriatric Medicine, Endocrinology, Lipidology and Hypertension Specialists. Healthcare professionals including physician assistants and nurse practitioners specializing in these areas or those managing patients with Hypertension, Diabetes, and/or Hyperlipidemia, alone or in combination, may benefit from this activity.